1.Department of Hospital Office, Qinhuai District Medical Area of General Hospital of Eastern Theater Command, Jiangsu Province, Nanjing 210002, China; 2.Department of Orthopedics, Qinhuai District Medical Area of General Hospital of Eastern Theater Command, Jiangsu Province, Nanjing 210002, China
Abstract：MicroRNA (miRNA) is a class of small non-coding single-stranded RNA with a length of 22 nucleotides, which is mainly responsible for the regulation of gene post-transcriptional expression. Previous studies have confirmed that miRNA plays an important regulatory role in the pathophysiological processes of cell growth and development, differentiation, proliferation, and apoptosis. In recent years, studies have found that the abnormal expression of miRNA is closely related to the occurrence and development of osteosarcoma (OS), and regulation of miRNA can inhibit the progression of OS. In addition, studies have also shown that miRNA can be used as a marker of OS chemotherapy response and an important prognostic indicator of OS. Therefore, the role of miRNA in OS has become a hot research topic. In this paper, the research progress of miRNA in OS will be reviewed in order to provide theoretical basis for further research.
[1] Wang JY，Yang Y，Ma Y，et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma [J]. Biomed Pharmacother，2020，121：109627.
[2] Wozniak AL，Adams A，King KE，et al. The RNA binding protein FMR1 controls selective exosomal miRNA cargo loading during inflammation [J]. J Cell Biol，2020，219（10）：e201912074.
[3] Zhang KQ，Chu XD. GANT61 plays antitumor effects by inducing oxidative stress through the miRNA-1286/RAB31 axis in osteosarcoma [J]. Cell Biol Int，2021，45（1）：61-73.
[4] Calin GA，Cimmino A，Fabbri M，et al. MiR-15a and miR- 16-1 cluster functions in human leukemia [J]. Proc Natl Acad Sci U S A，2008，105（13）：5166-5171.
[5] Huang YZ，Zhang J，Shen JJ，et al. miRNA-296-5p functions as a potential tumor suppressor in human osteosarcoma by targeting SND1 [J]. Chin Med J （Engl），2021，134（5）：564-572.
[6] Gao J，Yang TT，Qiu XC，et al. Cloning and identification of microRNA from human osteosarcoma cell line SOSP-9607 [J]. Ai Zheng，2007，26（6）：561-565.
[7] Guo J，Dong Q，Fang Z，et al. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma [J]. Cancer Biol Ther，2010，9（6）：446-452.
[8] He C，Xiong J，Xu X，et al. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples [J]. Biochem Biophys Res Commun，2009，388（1）：35-40.
[9] Asangani IA，Rasheed SA，Nikolova DA，et al. MicroRNA- 21（miR-21）post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion， intravasation and metastasis in colorectal cancer [J]. Oncogene，2008，27（15）：2128-2136.
[10] Hernando E. microRNAs and cancer：role in tumorigenesis，patient classification and therapy [J]. Clin Transl Oncol，2007，9（3）：155-160.
[11] Ziyan W，Shuhua Y，Xiufang W，et al. MicroRNA-21 is involved in osteosarcoma cell invasion and migration [J]. Med Oncol，2011，28（4）：1469-1474.
[12] Zhang H，Cai X，Wang Y，et al. microRNA-143，down- regulated in osteosarcoma，promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 [J]. Oncol Rep，2010，24（5）：1363-1369.
[13] Kim S，Lee UJ，Kim MN，et al. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 （ERK2） [J]. J Biol Chem，2008，283（26）：18158-18166.
[14] Jones KB，Salah Z，Del MS，et al. miRNA signatures associate with pathogenesis and progression of osteosarcoma [J]. Cancer Res，2012，72（7）：1865-1877.
[15] Thayanithy V，Sarver AL，Kartha RV，et al. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma [J]. Bone，2012，50（1）：171-181.
[16] Maire G，Martin JW，Yoshimoto M，et al. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma [J]. Cancer Genet，2011，204（3）：138-146.
[17] Duan Z，Choy E，Harmon D，et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration [J]. Mol Cancer Ther，2011，10（8）：1337-1345.
[18] Lulla RR，Costa FF，Bischof JM，et al. Identification of Differentially Expressed MicroRNAs in Osteosarcoma [J]. Sarcoma，2011，2011：732690.
[19] Chen DF，Zhang BW，Cao J，et al. Preparation of polycation with hydroxyls for enhanced delivery of miRNA in osteosarcoma therapy [J]. Biomater Sci，2022.
[20] Yao ZS，Li C，Liang D，et al. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma [J]. Cancer Biomark，2018，22（1）：127-133.
[21] Shi L，Xie C，Zhu J，et al. Downregulation of serum miR- 194 predicts poor prognosis in osteosarcoma patients [J]. Ann Diagn Pathol，2020，46：151488.
[22] Li Q，Song S，Ni G，et al. Serum miR-542-3p as a prognostic biomarker in osteosarcoma [J]. Cancer Biomark，2018，21（3）：521-526.
[23] Yoshida A，Fujiwara T，Uotani K，et al. Clinical and Functional Significance of Intracellular and Extracellular microRNA-25-3p in Osteosarcoma [J]. Acta Med Okayama，2018，72（2）：165-174.
[24] Gong N，Gong M. MiRNA-221 from tissue may predict the prognosis of patients with osteosarcoma [J]. Medicine （Baltimore），2018，97（29）：e11100.
[25] Chen K，Pan G. Dysregulation of microRNA-106a-5p- RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients [J]. Pathol Res Pract，2019， 215（12）：152686.
[26] Shi X，Guan X. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation， migration and invasion [J]. Diagn Pathol，2019，14（1）：117.
[27] Braun CJ，Zhang X，Savelyeva I，et al. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest [J]. Cancer Res，2008，68（24）：10094-10104.
[28] Yan K，Gao J，Yang T，et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo [J]. PLoS One，2012，7（3）：e33778.
[29] Creighton CJ，Fountain MD，Yu Z，et al. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers [J]. Cancer Res，2010，70（5）：1906-1915.
[30] Saito Y，Liang G，Egger G，et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells [J]. Cancer Cell，2006，9（6）：435-443.
[31] Gong Y，Wei Z，Liu J. MiRNA-1225 Inhibits Osteosarcoma Tumor Growth and Progression by Targeting YWHAZ [J]. Onco Targets Ther，2021，14：15-27.
[32] Luo Y，Liu W，Tang P，et al. miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells [J]. J Exp Clin Cancer Res，2019，38（1）：488.
[33] Sun X，Dai G，Yu L，et al. miR-143-3p inhibits the proliferation，migration and invasion in osteosarcoma by targeting FOSL2 [J]. Sci Rep，2018，8（1）：606.
[34] Palmini G，Marini F，Brandi ML. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma? [J]. Molecules，2017，22（3）：417.
[35] Song B，Wang Y，Xi Y，et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells [J]. Oncogene，2009，28（46）：4065-4074.
[36] Song B，Wang Y，Titmus MA，et al. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells [J]. Mol Cancer，2010，9：96.
[37] Liu LH，Li H，Li JP，et al. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down- regulation of STAT3 [J]. Biochem Biophys Res Commun，2011，416（1-2）：31-38.
[38] Kang HG，Kim HS，Kim KJ，et al. RECK expression in osteosarcoma：correlation with matrix metalloproteinases activation and tumor invasiveness [J]. J Orthop Res，2007，25（5）：696-702.
[39] Zhu J，Feng Y，Ke Z，et al. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin [J]. Am J Pathol，2012，180（6）：2440-2451.
[40] Gougelet A，Pissaloux D，Besse A，et al. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response [J]. Int J Cancer，2011，129（3）：680-690.
京公网安备 11010502046598号